Wealthspire Advisors, LLC Abbott Laboratories Transaction History

Wealthspire Advisors, LLC

$9.71 Billion
Q3 2024

A detailed history of Wealthspire Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Wealthspire Advisors, LLC holds 39,129 shares of ABT stock, worth $4.49 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

39,129

Previous 37,666 3.88%

Holding current value

$4.49 Million

Previous $3.91 Million 14.0%

% of portfolio

0.05%

Previous 0.05%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$100.07 - $118.13 $146,402 - $172,824	1,463 Added 3.88%	39,129 $4.46 Million
Q2 2024 Aug 08, 2024	SELL	$100.73 - $112.44 $92,369 - $103,107	-917 Reduced 2.38%	37,666 $3.91 Million
Q1 2024 May 06, 2024	SELL	$109.52 - $120.96 $170,303 - $188,092	-1,555 Reduced 3.87%	38,583 $4.39 Million
Q4 2023 Feb 06, 2024	SELL	$90.19 - $110.4 $50,506 - $61,824	-560 Reduced 1.38%	40,138 $4.42 Million
Q3 2023 Nov 06, 2023	BUY	$95.53 - $114.62 $363,014 - $435,556	3,800 Added 10.3%	40,698 $3.94 Million
Q2 2023 Jul 31, 2023	BUY	$100.78 - $112.29 $89,996 - $100,274	893 Added 2.48%	36,898 $4.02 Million
Q1 2023 May 09, 2023	SELL	$96.86 - $114.01 $444,006 - $522,621	-4,584 Reduced 11.29%	36,005 $3.65 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $390,126 - $457,678	4,104 Added 11.25%	40,589 $4.46 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $15,868 - $18,372	164 Added 0.45%	36,485 $3.53 Million
Q2 2022 Aug 09, 2022	BUY	$102.07 - $123.37 $1.82 Million - $2.2 Million	17,844 Added 96.57%	36,321 $3.95 Million
Q1 2022 May 09, 2022	SELL	$114.02 - $139.04 $917,062 - $1.12 Million	-8,043 Reduced 30.33%	18,477 $2.19 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $77,405 - $94,778	670 Added 2.59%	26,520 $3.73 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $962,211 - $1.06 Million	8,248 Added 46.86%	25,850 $3.05 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $5.81 Million - $6.84 Million	-54,951 Reduced 75.74%	17,602 $2.04 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $1.16 Million - $1.37 Million	10,701 Added 17.3%	72,553 $8.7 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $2.49 Million - $2.71 Million	23,721 Added 62.21%	61,852 $6.77 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $736,877 - $894,882	8,041 Added 26.72%	38,131 $4.15 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $1.2 Million - $1.53 Million	-15,632 Reduced 34.19%	30,090 $2.75 Million
Q1 2020 May 12, 2020	BUY	$62.82 - $91.86 $2.29 Million - $3.35 Million	36,516 Added 396.65%	45,722 $3.61 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $357,691 - $398,194	4,556 Added 97.98%	9,206 $800,000
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $380,556 - $412,641	4,650 New	4,650 $389,000
Q1 2019 May 08, 2019	SELL	$66.22 - $80.06 $65,888 - $79,659	-995 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $65,232 - $73,898	995 New	995 $72,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthspire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthspire Advisors, LLC with notifications on news.

Account

Wealthspire Advisors, LLC Abbott Laboratories Transaction History